What Happened?
, -based Mirati Therapeutics Promoted Betsy Gelfand as Chief Accounting Officer (CAO)
About the Company
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet medical need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Unified for patients, Mirati`s vision is to unlock the science behind the promise of a life beyond cancer.
About the Person
Betsy Gelfand is Chief Accounting Officer (CAO) at Mirati Therapeutics. Previously, Betsy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile